Global In Situ Hybridization (ISH) Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 96

Report ID: 19745

In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand (i.e., probe) to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small enough (e.g., plant seeds, Drosophila embryos), in the entire tissue (whole mount ISH), in cells, and in circulating tumor cells (CTCs).
Increase in incidence of chronic diseases, coupled with need for rapid diagnostic techniques, is contributing to the increase in adoption of ISH.
In 2018, the global In Situ Hybridization (ISH) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global In Situ Hybridization (ISH) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the In Situ Hybridization (ISH) development in United States, Europe and China.

The key players covered in this study
Thermo Fisher Scientific
Leica BiosystemsNussloch GmbH
BIOVIEW
Agilent Technologies
Merck KGaA
PerkinElmer Inc.
Bio-Rad Laboratories Inc.
NeoGenomics Laboratories Inc.
Advanced Cell Diagnostics Inc.
Oxford Gene Technology

Market segment by Type, the product can be split into
Instruments
Kits & Probes
Software
Services

Market segment by Application, split into
Cancer
Cytogenetics
Developmental Biology
Infectious Diseases
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global In Situ Hybridization (ISH) status, future forecast, growth opportunity, key market and key players.
To present the In Situ Hybridization (ISH) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of In Situ Hybridization (ISH) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global In Situ Hybridization (ISH) Market Size Growth Rate by Type (2014-2025)
1.4.2 Instruments
1.4.3 Kits & Probes
1.4.4 Software
1.4.5 Services
1.5 Market by Application
1.5.1 Global In Situ Hybridization (ISH) Market Share by Application (2014-2025)
1.5.2 Cancer
1.5.3 Cytogenetics
1.5.4 Developmental Biology
1.5.5 Infectious Diseases
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 In Situ Hybridization (ISH) Market Size
2.2 In Situ Hybridization (ISH) Growth Trends by Regions
2.2.1 In Situ Hybridization (ISH) Market Size by Regions (2014-2025)
2.2.2 In Situ Hybridization (ISH) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 In Situ Hybridization (ISH) Market Size by Manufacturers
3.1.1 Global In Situ Hybridization (ISH) Revenue by Manufacturers (2014-2019)
3.1.2 Global In Situ Hybridization (ISH) Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global In Situ Hybridization (ISH) Market Concentration Ratio (CR5 and HHI)
3.2 In Situ Hybridization (ISH) Key Players Head office and Area Served
3.3 Key Players In Situ Hybridization (ISH) Product/Solution/Service
3.4 Date of Enter into In Situ Hybridization (ISH) Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global In Situ Hybridization (ISH) Market Size by Type (2014-2019)
4.2 Global In Situ Hybridization (ISH) Market Size by Application (2014-2019)

5 United States
5.1 United States In Situ Hybridization (ISH) Market Size (2014-2019)
5.2 In Situ Hybridization (ISH) Key Players in United States
5.3 United States In Situ Hybridization (ISH) Market Size by Type
5.4 United States In Situ Hybridization (ISH) Market Size by Application

6 Europe
6.1 Europe In Situ Hybridization (ISH) Market Size (2014-2019)
6.2 In Situ Hybridization (ISH) Key Players in Europe
6.3 Europe In Situ Hybridization (ISH) Market Size by Type
6.4 Europe In Situ Hybridization (ISH) Market Size by Application

7 China
7.1 China In Situ Hybridization (ISH) Market Size (2014-2019)
7.2 In Situ Hybridization (ISH) Key Players in China
7.3 China In Situ Hybridization (ISH) Market Size by Type
7.4 China In Situ Hybridization (ISH) Market Size by Application

8 Japan
8.1 Japan In Situ Hybridization (ISH) Market Size (2014-2019)
8.2 In Situ Hybridization (ISH) Key Players in Japan
8.3 Japan In Situ Hybridization (ISH) Market Size by Type
8.4 Japan In Situ Hybridization (ISH) Market Size by Application

9 Southeast Asia
9.1 Southeast Asia In Situ Hybridization (ISH) Market Size (2014-2019)
9.2 In Situ Hybridization (ISH) Key Players in Southeast Asia
9.3 Southeast Asia In Situ Hybridization (ISH) Market Size by Type
9.4 Southeast Asia In Situ Hybridization (ISH) Market Size by Application

10 India
10.1 India In Situ Hybridization (ISH) Market Size (2014-2019)
10.2 In Situ Hybridization (ISH) Key Players in India
10.3 India In Situ Hybridization (ISH) Market Size by Type
10.4 India In Situ Hybridization (ISH) Market Size by Application

11 Central & South America
11.1 Central & South America In Situ Hybridization (ISH) Market Size (2014-2019)
11.2 In Situ Hybridization (ISH) Key Players in Central & South America
11.3 Central & South America In Situ Hybridization (ISH) Market Size by Type
11.4 Central & South America In Situ Hybridization (ISH) Market Size by Application

12 International Players Profiles
12.1 Thermo Fisher Scientific
12.1.1 Thermo Fisher Scientific Company Details
12.1.2 Company Description and Business Overview
12.1.3 In Situ Hybridization (ISH) Introduction
12.1.4 Thermo Fisher Scientific Revenue in In Situ Hybridization (ISH) Business (2014-2019)
12.1.5 Thermo Fisher Scientific Recent Development
12.2 Leica BiosystemsNussloch GmbH
12.2.1 Leica BiosystemsNussloch GmbH Company Details
12.2.2 Company Description and Business Overview
12.2.3 In Situ Hybridization (ISH) Introduction
12.2.4 Leica BiosystemsNussloch GmbH Revenue in In Situ Hybridization (ISH) Business (2014-2019)
12.2.5 Leica BiosystemsNussloch GmbH Recent Development
12.3 BIOVIEW
12.3.1 BIOVIEW Company Details
12.3.2 Company Description and Business Overview
12.3.3 In Situ Hybridization (ISH) Introduction
12.3.4 BIOVIEW Revenue in In Situ Hybridization (ISH) Business (2014-2019)
12.3.5 BIOVIEW Recent Development
12.4 Agilent Technologies
12.4.1 Agilent Technologies Company Details
12.4.2 Company Description and Business Overview
12.4.3 In Situ Hybridization (ISH) Introduction
12.4.4 Agilent Technologies Revenue in In Situ Hybridization (ISH) Business (2014-2019)
12.4.5 Agilent Technologies Recent Development
12.5 Merck KGaA
12.5.1 Merck KGaA Company Details
12.5.2 Company Description and Business Overview
12.5.3 In Situ Hybridization (ISH) Introduction
12.5.4 Merck KGaA Revenue in In Situ Hybridization (ISH) Business (2014-2019)
12.5.5 Merck KGaA Recent Development
12.6 PerkinElmer Inc.
12.6.1 PerkinElmer Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 In Situ Hybridization (ISH) Introduction
12.6.4 PerkinElmer Inc. Revenue in In Situ Hybridization (ISH) Business (2014-2019)
12.6.5 PerkinElmer Inc. Recent Development
12.7 Bio-Rad Laboratories Inc.
12.7.1 Bio-Rad Laboratories Inc. Company Details
12.7.2 Company Description and Business Overview
12.7.3 In Situ Hybridization (ISH) Introduction
12.7.4 Bio-Rad Laboratories Inc. Revenue in In Situ Hybridization (ISH) Business (2014-2019)
12.7.5 Bio-Rad Laboratories Inc. Recent Development
12.8 NeoGenomics Laboratories Inc.
12.8.1 NeoGenomics Laboratories Inc. Company Details
12.8.2 Company Description and Business Overview
12.8.3 In Situ Hybridization (ISH) Introduction
12.8.4 NeoGenomics Laboratories Inc. Revenue in In Situ Hybridization (ISH) Business (2014-2019)
12.8.5 NeoGenomics Laboratories Inc. Recent Development
12.9 Advanced Cell Diagnostics Inc.
12.9.1 Advanced Cell Diagnostics Inc. Company Details
12.9.2 Company Description and Business Overview
12.9.3 In Situ Hybridization (ISH) Introduction
12.9.4 Advanced Cell Diagnostics Inc. Revenue in In Situ Hybridization (ISH) Business (2014-2019)
12.9.5 Advanced Cell Diagnostics Inc. Recent Development
12.10 Oxford Gene Technology
12.10.1 Oxford Gene Technology Company Details
12.10.2 Company Description and Business Overview
12.10.3 In Situ Hybridization (ISH) Introduction
12.10.4 Oxford Gene Technology Revenue in In Situ Hybridization (ISH) Business (2014-2019)
12.10.5 Oxford Gene Technology Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details